GlassScriptPhysician profile
Pauline Hsu
NPI 1134152416
$1,380.80
in general payments reported to CMS, 2019-2025
20 companies · $58.02 in 2025
The $58.02 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $131 · 2021: $49.36 · 2022: $111 · 2023: $264 · 2024: $455 · 2025: $58.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $280.23 | 2019-2024 | Ozempic, Rybelsus |
| Amgen INC. | $165.17 | 2019-2024 | Repatha, Otezla, Krystexxa |
| Merck Sharp & Dohme LLC | $163.90 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Exact Sciences Corporation | $142.65 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $126.00 | 2019-2023 | |
| Cranial Technologies, INC | $125.53 | 2019-2025 | Doc Band |
| Pfizer INC. | $50.35 | 2019-2020 | |
| Abbott Laboratories | $48.05 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $48.02 | 2019-2025 | Bexsero, Pediarix |
| Astrazeneca Pharmaceuticals LP | $40.55 | 2019-2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $34.76 | 2023 | Givlaari |
| Daiichi Sankyo INC. | $25.30 | 2024 | Injectafer |
| Lilly USA, LLC | $20.11 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $18.65 | 2022 | |
| Hologic Sales and Service, LLC | $17.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $17.43 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.12 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.40 | 2019 | |
| Sanofi Pasteur INC. | $12.07 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pauline Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.